Clofarabine treatment of <i>KMT2A</i>r infantile patients with acute lymphoblastic leukemia in St. Jude Total Therapy Study 16-Reference-Cited by-同舟云学术

Clofarabine treatment of KMT2Ar infantile patients with acute lymphoblastic leukemia in St. Jude Total Therapy Study 16

Published:2022-12-27 Issue:24 Volume:6 Page:6131-6134
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Gruber Tanja A.¹^ORCID,Pei Deqing²,Choi John³^ORCID,Cheng Cheng²,Coustan-Smith Elaine⁴,Campana Dario⁴,Swanson Hope D.⁵,Pauley Jennifer L.⁶,Inaba Hiroto⁷,Metzger Monika L.⁶⁷,Rubnitz Jeffrey E.⁷^ORCID,Ribeiro Raul C.⁷^ORCID,Raimondi Susana C.⁸,Pui Ching-Hon⁶⁷^ORCID,Jeha Sima⁶⁷

Affiliation:

1. 1Department of Pediatrics, Stanford University School of Medicine, Stanford, CA

2. 2Department of Biostatistics, St. Jude Children’s Research Hospital, Memphis, TN

3. 3Department of Pathology, University of Alabama at Birmingham, Birmingham, AL

4. 4Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

5. 5Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN

6. 6Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN

7. 7Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN

8. 8Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN

Publisher

American Society of Hematology

Subject

Hematology

Link

https://ashpublications.org/bloodadvances/article-pdf/6/24/6131/2026620/blooda_adv-2022-008557-main.pdf

Reference15 articles.

1. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial;Pieters;Lancet,2007

2. Outcome of infants younger than 1 year with acute lymphoblastic leukemia treated with the interfant-06 protocol: results from an international phase III randomized study;Pieters;J Clin Oncol,2019

3. FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631;Brown;Leukemia,2021

4. Improved CNS control of childhood acute lymphoblastic leukemia without cranial irradiation: St Jude total therapy study 16;Jeha;J Clin Oncol,2019

5. Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia;Jeha;J Clin Oncol,2006

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infant Acute Lymphoblastic Leukemia—New Therapeutic Opportunities;International Journal of Molecular Sciences;2024-03-27

2. Patient-Level Meta-analysis of Clofarabine in Acute Lymphoblastic Leukemia;Advances in Therapy;2023-10-11

3. Updates in KMT2A Gene Rearrangement in Pediatric Acute Lymphoblastic Leukemia;Biomedicines;2023-03-08